Panacea biotec ltd, Pharmaceutical company

One of India's largest vaccine and pharmaceutical company 'Panacea Biotec' in collaboration with the Russian Direct Investment Fund (RDIF) has agreed to produce 100 million doses per year of COVID-19 vaccine Sputnik V, the world's first registered vaccine against coronavirus.According to a press release, Panacea Biotec Ltd (PBL) has announced that the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India has agreed to cooperate to produce 100 million doses per year of Sputnik V.Earlier last month, the RDIF and Hyderabad-based Virchow Biotech Private Limited inked an agreement to produce up to 200 million doses per year of Sputnik V vaccine (Russian made) in India.Sputnik V has been registered in 54 countries globally with a total population of over 1.4 billion people. The efficacy of Sputnik V is 91.6 per cent as confirmed by the data published in the Lancet, one of the world's oldest and most respected medical journals.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Narendra Modi

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Panacea Biotec LtdFOLLOW

Panacea biotec ltd, Latest News

National :Delhi HC anguished over shortage of COVID vaccines in India

The Delhi High Court on Friday expressed anguish over COVID-19 vaccine shortage and "the way things have transpired during the second wave". ...

International :COVID-19: RDIF collabs with Panacea Biotec to produce 100 million doses of Sputnik V vaccine in India

One of India's largest vaccine and pharmaceutical company 'Panacea Biotec' in collaboration with the Russian Direct Investment Fund (RDIF) has agreed to produce 100 million doses per year of COVID-19 vaccine Sputnik V, the world's first registered va ...